State Street’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,907
Closed -$9K 4960
2022
Q3
$9K Hold
33,907
﹤0.01% 4898
2022
Q2
$12K Hold
33,907
﹤0.01% 4918
2022
Q1
$23K Hold
33,907
﹤0.01% 4876
2021
Q4
$78K Hold
33,907
﹤0.01% 4625
2021
Q3
$155K Buy
33,907
+9,100
+37% +$40K ﹤0.01% 4439
2021
Q2
$110K Sell
24,807
-208,732
-89% -$1.06M ﹤0.01% 4342
2021
Q1
$1.7M Buy
233,539
+18,781
+9% +$155K ﹤0.01% 3499
2020
Q4
$1.64M Buy
214,758
+57,093
+36% +$382K ﹤0.01% 3435
2020
Q3
$1.43M Sell
157,665
-420
-0.3% -$3.19K ﹤0.01% 3326
2020
Q2
$1.34M Buy
158,085
+30,845
+24% +$203K ﹤0.01% 3329
2020
Q1
$629K Sell
127,240
-208
-0.2% -$1.62K ﹤0.01% 3402
2019
Q4
$918K Buy
127,448
+8,175
+7% +$73.9K ﹤0.01% 3424
2019
Q3
$1.29M Sell
119,273
-652
-0.5% -$6.97K ﹤0.01% 3347
2019
Q2
$1.56M Buy
119,925
+51,478
+75% +$683K ﹤0.01% 3329
2019
Q1
$676K Buy
68,447
+8,329
+14% +$77.6K ﹤0.01% 3404
2018
Q4
$625K Buy
+60,118
New +$726K ﹤0.01% 3414